Radiopharm Theranostics Ltd (RAD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | |
| Cash Flows From Operating Activities | ||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | 0 | N/A | -45 | -3 |
| Purchase Sale Intangibles | 2,998 | N/A | -1,485 | -28,336 |
| Other Investing Activity | 1,771 | 0 | 0 | -31 |
| Investing Cash Flow | $1,771 | $N/A | $-1,531 | $-28,370 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 0 | 7,369 | N/A | 10 |
| Debt Repayment | -1,900 | -5,167 | N/A | -69 |
| Common Stock Issued | 53,978 | 29,646 | 10,073 | 70,000 |
| Other Financing Activity | -6,646 | -1,971 | -855 | -4,831 |
| Financing Cash Flow | $45,432 | $29,877 | $9,218 | $65,110 |
| Exchange Rate Effect | -15 | -25 | 235 | 127 |
| Beginning Cash Position | 18,575 | 11,699 | 26,979 | 27 |
| End Cash Position | 29,117 | 18,575 | 11,699 | 26,979 |
| Net Cash Flow | $10,557 | $6,901 | $-15,515 | $26,825 |
| Free Cash Flow | ||||
| Capital Expenditure | N/A | N/A | -1,531 | -28,339 |
| Free Cash Flow | 0 | 0 | -1,531 | -28,339 |